Norway· NO-ID_49C7D5CE-8554-443F-9458-A86F08997485
Vyxeos liposomal
A cytarabine and daunorubicin product containing daunorubicin hydrochloride + cytarabine, registered in Norway by Jazz Pharmaceuticals Ireland Limited. The same ATC class is registered in 13 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Cytarabine and daunorubicin is registered in 13 of 19 countries.
Countries holding a registration under ATC L01XY01 (cytarabine and daunorubicin), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 8 of them publish a price we can compare per daily dose
Cytarabine and daunorubicin · ATC L01XY01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Daunorubicin Hydrochloride + Cytarabine
- Manufacturer
- Jazz Pharmaceuticals Ireland Limited
- Country
- Norway (NO)
- ATC code
- L01XY01
- ATC class
- Cytarabine and daunorubicin
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_49C7D5CE-8554-443F-9458-A86F08997485
- no_varenummer1483881NOK 67896.5
- gtin0368727001299
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Cytarabine and daunorubicin in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaVYXEOS LIPOSOMALJazz Pharmaceuticals Ireland Ltd, Dublin
- SwitzerlandVyxeos liposomal 44 mg/100 mg, Pulver für ein Konzentrat zur Herstellung einer InfusionsdispersionJazz Pharmaceuticals Switzerland GmbH
- FinlandVyxeos liposomalJazz Pharmaceuticals Ireland Limited
- United KingdomVyxeos liposomal 44mg/100mg powder for concentrate for solution for infusion vialsJazz Pharmaceuticals UK Ltd
- IrelandVyxeos liposomal 44 mg/100 mg powder for concentrate for solution for infusionJazz Pharmaceuticals Ireland Limited
- IcelandVyxeos liposomalJazz Pharmaceuticals Ireland Ltd
- NetherlandsVyxeos liposomal 44 mg/100 mg poeder voor concentraat voor oplossing voor infusieJazz Pharmaceuticals Ireland Limited
- PolandVyxeos liposomalJazz Pharmaceuticals Ireland Ltd
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Vyxeos Liposomal
- Liechtenstein · Vyxeos Liposomal
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f6564607-0549-4068-8fa7-81c35c6d14ba GET /v1/drugs/f6564607-0549-4068-8fa7-81c35c6d14ba?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pulver til konsentrat til infusjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Cytarabin og daunorubicin",
"merkevare_id": "ID_49C7D5CE-8554-443F-9458-A86F08997485",
"name_form_strength": "Vyxeos liposomal pulv til kons til inf væske, oppl 44 mg/100 mg",
"prescription_group": "C"
}See everything about cytarabine and daunorubicin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.